Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (391-400 of 692) with videos related to

Pageof 70
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2002
Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancerRodolfo Nuñez, Homer A Macapinlac, Henry W D Yeung, et al.
Cancer Research|June 15, 1991
Clinical pharmacology of deoxyspergualin in patients with advanced cancerJ F Muindi, S J Lee, L Baltzer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancerMargaret A Leversha, Jialian Han, Zahra Asgari, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 7, 2001
Inverse associations between plasma lycopene and other carotenoids and prostate cancerQ Y Lu, J C Hung, D Heber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVACA S Sarkis, D F Bajorin, V E Reuter, et al.
European Urology|July 15, 2014
Impact of baseline corticosteroids on survival and steroid androgens in metastatic castration-resistant prostate cancer: exploratory analysis from COU-AA-301Bruce Montgomery, Thian Kheoh, Arturo Molina, et al.
Cephalalgia : an International Journal of Headache|December 12, 2012
Lack of association between the MTHFR C677T variant and migraine with aura in an older population: could selective survival play a role?Ann I Scher, Gudny Eiriksdottir, Melissa Garcia, et al.
Scientific Reports|July 1, 2016
Small Glutamine-Rich Tetratricopeptide Repeat-Containing Protein Alpha (SGTA) Ablation Limits Offspring Viability and Growth in MiceLisa K Philp, Tanya K Day, Miriam S Butler, et al.
Cancer Research|October 15, 1992
Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expressionR J Motzer, D M Nanus, P O'Moore, et al.
European Urology|April 21, 2009
Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancerMichael J Morris, Daisy Huang, William K Kelly, et al.
Pageof 70

Showing results (391-400 of 692) with videos related to

Sort By:
Pageof 70
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2002
Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancerRodolfo Nuñez, Homer A Macapinlac, Henry W D Yeung, et al.
Cancer Research|June 15, 1991
Clinical pharmacology of deoxyspergualin in patients with advanced cancerJ F Muindi, S J Lee, L Baltzer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancerMargaret A Leversha, Jialian Han, Zahra Asgari, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 7, 2001
Inverse associations between plasma lycopene and other carotenoids and prostate cancerQ Y Lu, J C Hung, D Heber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVACA S Sarkis, D F Bajorin, V E Reuter, et al.
European Urology|July 15, 2014
Impact of baseline corticosteroids on survival and steroid androgens in metastatic castration-resistant prostate cancer: exploratory analysis from COU-AA-301Bruce Montgomery, Thian Kheoh, Arturo Molina, et al.
Cephalalgia : an International Journal of Headache|December 12, 2012
Lack of association between the MTHFR C677T variant and migraine with aura in an older population: could selective survival play a role?Ann I Scher, Gudny Eiriksdottir, Melissa Garcia, et al.
Scientific Reports|July 1, 2016
Small Glutamine-Rich Tetratricopeptide Repeat-Containing Protein Alpha (SGTA) Ablation Limits Offspring Viability and Growth in MiceLisa K Philp, Tanya K Day, Miriam S Butler, et al.
Cancer Research|October 15, 1992
Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expressionR J Motzer, D M Nanus, P O'Moore, et al.
European Urology|April 21, 2009
Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancerMichael J Morris, Daisy Huang, William K Kelly, et al.
Pageof 70